Epirubicin
Epirubicin
Epirubicin (pronounced as e-pi-roo-bi-sin) is a chemotherapy drug used in the treatment of various types of cancer, including breast cancer, gastric cancer, lung cancer, and ovarian cancer. It belongs to the class of drugs known as anthracyclines, which work by interfering with the DNA in cancer cells, preventing them from dividing and growing.
Etymology
The term "Epirubicin" is derived from the Greek words "epi-", meaning "upon" or "over", and "rubicin", referring to the class of drugs known as anthracyclines. The "epi-" prefix is used because Epirubicin is a derivative of another anthracycline drug, Doxorubicin.
Usage
Epirubicin is typically administered intravenously, often as part of a combination chemotherapy regimen. The dosage and frequency of administration depend on the type of cancer being treated, the patient's overall health, and other factors.
Side Effects
Like all chemotherapy drugs, Epirubicin can cause side effects. These may include nausea, vomiting, hair loss, and fatigue. More serious side effects can include heart damage, low blood cell counts, and infection.
Related Terms
- Anthracyclines: A class of drugs used in chemotherapy that interfere with the DNA in cancer cells.
- Chemotherapy: The use of drugs to kill cancer cells or slow their growth.
- Doxorubicin: Another anthracycline drug, from which Epirubicin is derived.
External links
- Medical encyclopedia article on Epirubicin
- Wikipedia's article - Epirubicin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski